Major Shareholder's Potential Stake Reduced to 15.8% as Rights Expire

summarizeSummary

A major shareholder's potential beneficial ownership in Celularity Inc. has been reduced to 15.8% after rights to acquire additional shares expired, clarifying their current maximum stake.

check_boxKey Events

• Beneficial Ownership Updated

  The Philip & Daniele Barach Family Trust now beneficially owns 5,414,686 shares, representing 15.8% of Celularity Inc.'s Class A Common Stock.

• Potential Stake Reduced

  The trust's right to acquire an additional 2,043,979 shares through convertible notes and warrants expired on June 19, 2026, reducing their maximum potential beneficial ownership from 20.1% to 15.8%.

• Warrants Became Exercisable

  Warrants to purchase 3,707,457 shares at an exercise price of $2.00 per share, issued on December 19, 2025, became exercisable on June 19, 2026.

auto_awesomeAnalysis

This amendment to a Schedule 13D clarifies the beneficial ownership of the Philip & Daniele Barach Family Trust in Celularity Inc. Their potential maximum stake has been reduced from 20.1% to 15.8% because their right to acquire additional convertible notes and warrants expired on June 19, 2026. While the trust remains a significant shareholder, this update indicates they are not increasing their investment beyond the current level, which could be viewed negatively given the company's recent delisting notice.